Cite
Serruys PW, Vranckx P, Slagboom T, et al. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention. 2008;3(5):600-9doi: 10.4244/eijv3i5a108.
Serruys, P. W., Vranckx, P., Slagboom, T., Regar, E., Meliga, E., de Winter, R. J., Heyndrickx, G., Schuler, G., van Remortel, E. A., Dubé, G. P., & Symons, J. (2008). Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3(5), 600-9. https://doi.org/10.4244/eijv3i5a108
Serruys, Patrick W, et al. "Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 3,5 (2008): 600-9. doi: https://doi.org/10.4244/eijv3i5a108
Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EA, Dubé GP, Symons J. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention. 2008 Mar;3(5):600-9. doi: 10.4244/eijv3i5a108. PMID: 19608488.
Copy
Download .nbib